community download

Presentation: FluBlok®: Gaining Regulatory Approval Following Phase 3 Studies

information we require

please check before submitting



Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

Dan Adams, Executive Chairman, Global Head of Business Development, Protein Sciences Corporation presented a case study at the World Influenza Congress in 2011, discussing his company’s product FluBlok®: Gaining Regulatory Approval Following Phase 3 Studies. His presentation was structured around the following points:

·                     Company overview: business segments

·                     Proprietary insect cell platform technology

·                     Lead vaccines: FluBlok® and PanBlok ®

·                     Quality by design

·                     Challenges to approval

·                     Take-home lessons

 

 Why not download the full presentation and find out more about FluBlok®!